DELIVERY ORDER
Active75N94026F00002
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH NICHD
$1.7M
obligated · signed 1 week ago
NICHD: R&D SERVICES: IN VIVO EFFICACY, VALIDATION AND PRECLINICAL DEVELOPMENT FOR FERTILITY REGULATION, MULTIPURPOSE PREVENTION TECHNOLOGY AND REPRODUCTIVE HEALTH RELATED PRODUCTS (REPRO TASK ORDER): NON-SEVERABLE
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2028
with all options
Loading status
Estimated start: Sep 29, 2027
SRI INTERNATIONAL
Contract 75N94026F00002
UEI
SRG2J1WS9X63
Parent Company
SRI INTERNATIONAL
Capabilities & Certifications
Headquarters Location
Congressional District: 16
Current Obligation
$1,719,885
Base + Exercised Options
$1,719,885
Total Ceiling Value
$1,719,885
Contract Type
COST PLUS FIXED FEE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Place of Performance
Congressional District: 16
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NICHD
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NICHD
Office
Contract Vehicle
75N94026D00001
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.